Analysts have provided the following ratings for Edwards Lifesciences EW within the last quarter:
Last 30 Days | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|
Bullish | 0 | 2 | 0 | 0 |
Somewhat Bullish | 0 | 6 | 1 | 1 |
Indifferent | 0 | 3 | 0 | 0 |
Somewhat Bearish | 0 | 0 | 0 | 0 |
Bearish | 0 | 0 | 0 | 0 |
In the last 3 months, 13 analysts have offered 12-month price targets for Edwards Lifesciences. The company has an average price target of $121.38 with a high of $135.00 and a low of $105.00.
This current average represents a 15.6% increase from the previous average price target of $105.0.
What Are Analyst Ratings?
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Analysts also give out recommendations like "buy", "sell", "hold", or similar verbage for each stock based on their overall evaluations of the corres ponding company. A "buy" indicates that an analyst is optimistic about a stock's short-term or mid-term growth, recommending traders to purchase the stock. Contrastingly, a "sell" means that an analyst believes the stock will trend downwards in that same time frame. A "hold" suggests that investors should not buy more of or sell any of the specified stock due to that analyst's prediction of stagnation.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.